Dr. Wachman received her MD from the BU School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal abstinence syndrome (NAS) quality improvement and research at BMC. Her research primarily focuses on examining genetic and epigenetic predictors of NAS outcomes. She is a site Co-Investigator of a NIDA clinical trial exploring optimal treatment options for NAS, as well as genetic variations and developmental outcomes in these high-risk infants. Her other primary research interests include the care of premature infants with NAS, and breastfeeding in the setting of maternal substance use disorders. Dr. Wachman has presented her research and numerous local and national conferences.
- Boston University School of Medicine, MD
- Georgetown University, BS
- Published on 6/18/2018
Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, Marro P, Oliveira EL, Harvey-Wilkes K, Czynski A, Engelhardt B, D'Apolito K, Bogen D, Lester B. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial. JAMA Pediatr. 2018 Jun 18. PMID: 29913015.
- Published on 5/8/2018
Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, Saia K, Nikita F, Khattab A, Nolin A, Alvarez C, Barry K, Combs G, Stickney D, Driscoll J, Humphreys R, Burke J, Farrell C, Shrestha H, Whalen BL. Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. J Perinatol. 2018 May 08. PMID: 29740196.
- Published on 4/9/2018
Schiff DM, Wachman EM, Philipp B, Joseph K, Shrestha H, Taveras EM, Parker MGK. Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads. Breastfeed Med. 2018 May; 13(4):266-274. PMID: 29630387.
- Published on 4/3/2018
Wachman EM, Schiff DM, Silverstein M. Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018 Apr 03; 319(13):1362-1374. PMID: 29614184.
- Published on 3/25/2018
Wachman EM, Hayes MJ, Shrestha H, Nikita FNU, Nolin A, Hoyo L, Daigle K, Jones HE, Nielsen DA. Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads. Genes Brain Behav. 2018 Mar 25. PMID: 29575474.
- Published on 9/1/2017
Vilkins AL, Bagley SM, Hahn KA, Rojas-Miguez F, Wachman EM, Saia K, Alford DP. Comparison of Post-Cesarean Section Opioid Analgesic Requirements in Women With Opioid Use Disorder Treated With Methadone or Buprenorphine. J Addict Med. 2017 Sep/Oct; 11(5):397-401. PMID: 28727661.
- Published on 7/17/2017
Schiff DM, Zuckerman B, Wachman EM, Bair-Merritt M. Trainees' knowledge, attitudes, and practices towards caring for the substance-exposed mother-infant dyad. Subst Abus. 2017 Oct-Dec; 38(4):414-421. PMID: 28715290.
- Published on 2/1/2017
Howard MB, Schiff DM, Penwill N, Si W, Rai A, Wolfgang T, Moses JM, Wachman EM. Impact of Parental Presence at Infants' Bedside on Neonatal Abstinence Syndrome. Hosp Pediatr. 2017 02; 7(2):63-69. PMID: 28137920.
- Published on 1/13/2017
Saia K, Bagley SM, Wachman EM, Patel PP, Nadas MD, Brogly SB. Prenatal treatment for opioid dependency: observations from a large inner-city clinic. Addict Sci Clin Pract. 2017 01 13; 12(1):5. PMID: 28086944.
- Published on 12/16/2016
Wachman EM, Hayes MJ, Sherva R, Brown MS, Shrestha H, Logan BA, Heller NA, Nielsen DA, Farrer LA. Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity. Am J Addict. 2017 Jan; 26(1):42-49. PMID: 27983768.
View 12 more publications: View full profile at BUMC